Britecyte® is a biotechnology company pioneering the development of regenerative medicine therapies. With a focus on the biocompatibility of tissues and cells, Britecyte is redefining the field of regenerative medicine through the development of groundbreaking tissue transplantation solutions to address unmet medical needs for many diseases and conditions. Committed to shaping the future of regenerative medicine, Britecyte continues to drive progress in the field with cutting-edge technology and a patient-centered approach.